Akeso, Inc. (HKG:9926)
Hong Kong · Delayed Price · Currency is HKD 124.50
+7.10 (6.05%)
At close: Dec 12, 2025
Akeso Market Cap
Akeso has a market cap or net worth of 114.68 billion as of December 12, 2025. Its market cap has increased by 81.62% in one year.
Market Cap
114.68B
Enterprise Value
111.75B
Revenue
2.75B
Ranking
n/a
PE Ratio
n/a
Stock Price
124.50
Market Cap Chart
Since April 24, 2020, Akeso's market cap has increased from 18.54B to 114.68B, an increase of 518.43%. That is a compound annual growth rate of 38.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 11, 2025 | 108.14B | 98.49% |
| Dec 31, 2024 | 54.48B | 39.61% |
| Dec 29, 2023 | 39.03B | 7.91% |
| Dec 30, 2022 | 36.17B | 30.19% |
| Dec 31, 2021 | 27.78B | -7.12% |
| Dec 31, 2020 | 29.91B | 61.28% |
| Apr 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 274.43B |
| Hansoh Pharmaceutical Group Company | 257.41B |
| JD Health International | 188.25B |
| Innovent Biologics | 143.10B |
| WuXi Biologics | 138.62B |
| Sino Biopharmaceutical | 121.03B |
| Sichuan Kelun-Biotech Biopharmaceutical | 96.12B |
| CSPC Pharmaceutical Group | 88.83B |